Table 1 The correlations between AGK expression and the clinicopathological features of the patients with epithelial ovarian cancer
Characteristics | Number of cases (%) | AGK expression (%) | P value | |
|---|---|---|---|---|
Low or no expression | High expression | |||
Age (years) | Â | Â | Â | 0.710 |
 <45 | 49 (35) | 18 (36.7) | 31 (63.2) |  |
  ≥ 45 | 91 (65) | 30 (33.0) | 61 (67.0) |  |
CA125 level | Â | Â | Â | 0.482 |
 <500 U/ml | 67 (47.9) | 25 (37.3) | 42 (62.7) |  |
  ≥ 500 U/ml | 73 (52.1) | 23 (31.5) | 50 (68.5) |  |
Tumor size | Â | Â | Â | 0.206 |
 <10 cm | 58 (41.4) | 16 (27.6) | 42 (72.4) |  |
  ≥ 10 cm | 82 (58.6) | 32 (39.0) | 50 (61.0) |  |
The volume of ascites | Â | Â | Â | 0.001 |
 <1000 ml | 100 (71.4) | 43 (43.0) | 57 (57.0) |  |
  ≥ 1000 ml | 40 (28.6) | 5 (12.5) | 35 (87.5) |  |
Peritoneal cytology | Â | Â | Â | 0.004 |
 Positive | 68 (48.6) | 15 (22.0) | 53 (78.0) |  |
 Negative | 72 (51.4) | 33 (45.8) | 39 (54.2) |  |
Pathological type | Â | Â | Â | 0.238 |
 Serous | 80 (57.1) | 25 (31.2) | 55 (68.8) |  |
 Mucinous | 14 (10.0) | 8 (57.1) | 6 (42.9) |  |
 Poorly differentiated | 36 (25.7) | 12 (33.3) | 24 (66.7) |  |
 Othersa | 10 (7.1) | 3 (30.0) | 7 (70.0) |  |
Grade of differentiation | Â | Â | Â | 0.376 |
 G1 | 59 (42.1) | 23 (39.0) | 36 (61.0) |  |
 G2 | 46 (32.9) | 14 (30.4) | 32 (69.6) |  |
 G3 | 18 (12.9) | 6 (33.3) | 12 (66.7) |  |
 Unknown | 17 (12.1) | 5 (29.4) | 12 (70.6) |  |
FIGO stage | Â | Â | Â | 0.002 |
 I | 30 (21.4) | 18 (60.0) | 12 (30.0) |  |
 II+ III + IV | 110 (78.6) | 32 (29.1) | 80 (70.9) |  |
Lymph node metastasis | Â | Â | Â | 0.688 |
 Positive | 21 (15.0) | 8 (38.1) | 13 (61.9) |  |
 Negative | 23 (16.4) | 7 (30.4) | 16 (69.6) |  |
 Not do RPLNDb | 96 (68.6) | 33 (34.4) | 63 (65.6) |  |
Cytoreductive surgeryc | Â | Â | Â | 0.812 |
 Optimal | 107 (76.4) | 35 (32.7) | 72 (67.3) |  |
 Suboptimal | 33 (23.6) | 13 (39.4) | 20 (60.6) |  |